Organizing committee invites all participants from all over the world to attend “3rd International Conference on Cardiovascular Diseases and Therapeutics’’ during April 01-02, 2020 in Paris, France.

CVDT 2020 will be an investigation of new research Innovation in the field of Cardiology and spread the most recent advancements in heart diseases prevention and rehabilitation. Argument on the new technology enhancement in the field of Cardiovascular Disease and current practices in Cardiovascular therapy, Cardiac progenitor cells, Hypertension for the primary care clinician, Stent procedure, Balloon Valvuloplasty, Coronary thrombectomy, Heart failure, Congestive heart failure, Noninvasive cardiac imaging, Sports Cardiology and more. Differentiating heart disease and other cardiac conditions constitute a team of healthcare professionals, of which the Cardiology technologist is a key player. The strength of the Conference is that the participants tend to include all phases of the value chain as well as individuals from a wide variety of sector and countries.

Why to attend???

• To Network
•  Expanding your knowledge and find solutions to problems
• To present your ideas and work to others
• For people to meet you.
• Learn beyond your field or interest

Target Audience:

• Associate Professors
• Registered Nurses
• Research Fellows
• Leading world Doctors,
• Directors
• Deans
• Professors
• Instructors and many more from leading universities
• companies and medical research institutions
• hospitals

Growth of Cardiology Market: -

North America is the dominant regional market for theheart diagnostics with a share of the approximately 47% of the overall heart diagnostics market in terms of revenue in 2018, followed by Europe which accounted for around 38% share in the market and then by Asia accounting for 16% share.

Scope and Importance: -

A prospective survey of patients with (VHD) Valvular heart disease .

Coronary angiography was used in 85.2% of the  patients before intervention.

The (EHS) Euro Heart Survey program has been initiated order to providethe quantitative information on cardiovascular diseases.

To prevent the incidence of(CV)cardiovascular disease, by implementing strategies to reduce the burden of Cardiovascular risk factors and incidence of cardiovascular disease and develop the appropriate models for healthy CV lifestyle.

Name : Jason Roy
Contact Number:+44 2039363178
Email: cardiovascular@europemeet.com
website:https://cardiovasculardiseases.cardiologymeeting.com/